These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30134546)

  • 41. APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.
    Weisblum Y; Oiknine-Djian E; Zakay-Rones Z; Vorontsov O; Haimov-Kochman R; Nevo Y; Stockheim D; Yagel S; Panet A; Wolf DG
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restoring immune defenses via lymphotoxin signaling: lessons from cytomegalovirus.
    Banks TA; Rickert S; Ware CF
    Immunol Res; 2006; 34(3):243-54. PubMed ID: 16891674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention.
    Trilling M; Le VT; Hengel H
    Future Microbiol; 2012 Nov; 7(11):1269-82. PubMed ID: 23075446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway.
    Miller DM; Rahill BM; Boss JM; Lairmore MD; Durbin JE; Waldman JW; Sedmak DD
    J Exp Med; 1998 Mar; 187(5):675-83. PubMed ID: 9480977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hcmv-miR-UL112 attenuates NK cell activity by inhibition type I interferon secretion.
    Huang Y; Chen D; He J; Cai J; Shen K; Liu X; Yang X; Xu L
    Immunol Lett; 2015 Feb; 163(2):151-6. PubMed ID: 25530545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. STAT2-Dependent Immune Responses Ensure Host Survival despite the Presence of a Potent Viral Antagonist.
    Le-Trilling VTK; Wohlgemuth K; Rückborn MU; Jagnjic A; Maaßen F; Timmer L; Katschinski B; Trilling M
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models.
    Lemmermann NA; Böhm V; Holtappels R; Reddehase MJ
    Virus Res; 2011 May; 157(2):161-74. PubMed ID: 20933556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of HLA expression in human cytomegalovirus immune evasion.
    Lin A; Xu H; Yan W
    Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex.
    Nightingale K; Potts M; Hunter LM; Fielding CA; Zerbe CM; Fletcher-Etherington A; Nobre L; Wang ECY; Strang BL; Houghton JW; Antrobus R; Suarez NM; Nichols J; Davison AJ; Stanton RJ; Weekes MP
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35105802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel Human Cytomegalovirus Viral Chemokines, vCXCL-1s, Display Functional Selectivity for Neutrophil Signaling and Function.
    Heo J; Dogra P; Masi TJ; Pitt EA; de Kruijf P; Smit MJ; Sparer TE
    J Immunol; 2015 Jul; 195(1):227-36. PubMed ID: 25987741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion.
    Biolatti M; Dell'Oste V; De Andrea M; Landolfo S
    New Microbiol; 2018 Apr; 41(2):87-94. PubMed ID: 29384558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment.
    Xie M; Xuan B; Shan J; Pan D; Sun Y; Shan Z; Zhang J; Yu D; Li B; Qian Z
    J Virol; 2015 Mar; 89(6):3049-61. PubMed ID: 25552713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
    Yang DR; Zhu HZ
    World J Gastroenterol; 2015 Apr; 21(13):3786-800. PubMed ID: 25852264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.
    López-Botet M; Muntasell A; Vilches C
    Semin Immunol; 2014 Apr; 26(2):145-51. PubMed ID: 24666761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Interactions of the Complement System with Human Cytomegalovirus.
    Lujan E; Zhang I; Garon AC; Liu F
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.
    Loewendorf A; Benedict CA
    J Intern Med; 2010 May; 267(5):483-501. PubMed ID: 20433576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human Cytomegalovirus Impact on mir-146a Expression Levels in Kidney Transplant Patients.
    Gambarino S; Ravanini P; Montanari P; Galliano I; Bergallo M
    Viral Immunol; 2016 Jun; 29(5):264-8. PubMed ID: 27077822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chromatin-Remodeling Factor SPOC1 Acts as a Cellular Restriction Factor against Human Cytomegalovirus by Repressing the Major Immediate Early Promoter.
    Reichel A; Stilp AC; Scherer M; Reuter N; Lukassen S; Kasmapour B; Schreiner S; Cicin-Sain L; Winterpacht A; Stamminger T
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploiting viral natural history for vaccine development.
    Barry PA
    Med Microbiol Immunol; 2015 Jun; 204(3):255-62. PubMed ID: 25794555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.